These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Public administration and R&D localisation by pharmaceutical and biotech companies: a theoretical framework and the Italian case-study. Jommi C, Paruzzolo S. Health Policy; 2007 Apr; 81(1):117-30. PubMed ID: 16824641 [Abstract] [Full Text] [Related]
26. Sustainability and the balancing of the health care and innovation agendas: the commercialization of genetic research. Caulfield T. Sask Law Rev; 2003 Apr; 66(2):629-45. PubMed ID: 15212021 [No Abstract] [Full Text] [Related]
27. The emergence of Egyptian biotechnology from generics. Abdelgafar B, Thorsteinsdóttir H, Quach U, Singer PA, Daar AS. Nat Biotechnol; 2004 Dec; 22 Suppl():DC25-30. PubMed ID: 15583680 [No Abstract] [Full Text] [Related]
35. [Medicen Paris Région: A world-class ''competitiveness cluster'' in the Paris region incorporating a neuroscience ''subcluster'']. Canet E. Med Sci (Paris); 2007 Apr; 23(4):435-9. PubMed ID: 17433236 [Abstract] [Full Text] [Related]
39. [The development of European Union common research and development policy and programs with special regard to life sciences]. Pörzse G. Orv Hetil; 2009 Aug 09; 150(32):1509-22. PubMed ID: 19632918 [Abstract] [Full Text] [Related]
40. Public-private partnerships advance contraceptive research and development. Harper MJ. Contraception; 2008 Oct 09; 78(4 Suppl):S36-41. PubMed ID: 18847598 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]